Levacetylleucine is an orally bioavailable and brain-penetrant acetylated derivative of amino acid Leucine. It is the active form of N-acetyl-leucine (NAL), shown to attenuate neuronal death and neuroinflammation, and potentially ameliorate lysosomal and metabolic dysfunction. This compound improves compensation of postural symptoms and is promising for research into neurological manifestations of Niemann-Pick disease type C, traumatic brain injury, and neurodegeneration prevention.
- Orally bioavailable and brain-penetrant
- Attenuates neuronal death and neuroinflammation
- Potentially ameliorates lysosomal and metabolic dysfunction
- Improves compensation of postural symptoms
- Suitable for research into neurological diseases and neurodegeneration prevention